---

---

treatment   tags : Research   

save search

---

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
PRCT A | $52.705 -1.94% 340K |

Manufacturing

| 6.16% | O: 0.91% H: 6.09% C: 5.21%
treatment aquablation research biorobotics for meeting therapy

---

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
Published: 2024-04-23 (Crawled : 07:00) - prnewswire.com
ONTX | $0.9953 -5.61% 1.3M |

Health Technology

| Email alert Add to watchlist
publication treatment research preclinical for leukemia

---

Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | News A | $11.485 1.1% 2.4M |

Health Technology

| 0.35% | O: -0.53% H: 0.0% C: -1.24%
NVS | News | $98.1 0.84% 1.3M |

Health Technology

| 4.95% | O: -1.46% H: 0.0% C: 0.0%
PHG | News | $20.92 -0.43% 350K |

Health Technology

| 1.64% | O: -1.21% H: 0.0% C: 0.0%
GSK | News | $40.835 -0.98% 1.1M |

Health Technology

| 1.83% | O: -1.19% H: 0.52% C: -0.17%
VRNA | $15.34 -1.6% 170K |

Health Technology

| -1.33% | O: 1.65% H: 2.43% C: 0.87%
reach treatment research market

---

Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
VTGN | $4.72 -2.28% 120K |

Health Technology

| -8.52% | O: -2.27% H: 0.0% C: 0.0%
positive treatment results study

---

SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
Published: 2024-03-25 (Crawled : 14:00) - globenewswire.com
SABS | $4.36 350 |

| -10.66% | O: 1.43% H: 0.0% C: -14.14%
partnership influenza treatment research medical potential

---

Hyperpigmentation Treatment Market to Reach $10.5 Billion, Globally, by 2032 at 7.5% CAGR: Allied Market Research
Published: 2024-03-11 (Crawled : 14:00) - prnewswire.com
FNCTF | News | $11.16 130 |

Communications

| Email alert Add to watchlist
reach treatment research market

---

Hawkins, Inc. Expands Water Treatment Footprint with Acquisition of Industrial Research Corporation
Published: 2024-03-11 (Crawled : 13:00) - globenewswire.com
HWKN 4 | $76.865 -0.11% 21K |

Distribution Services

| 10.82% | O: 0.69% H: 2.87% C: 2.56%
water corporation treatment acquisition research

---

FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
HUGE | News | $0.46 -5.93% 41K |

Process Industries

| -41.2% | O: -13.48% H: 15.52% C: 12.05%
pharma positive sclerosis treatment research results lucid-21-302 study

---

BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease
Published: 2024-03-04 (Crawled : 00:00) - biospace.com/
BDX | $234.07 -0.12% 480K |

Health Technology

| -0.4% | O: -0.4% H: 0.92% C: 0.55%
disease international treatment study

---

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-03-01 (Crawled : 12:30) - globenewswire.com
TGTX | $13.765 -3.4% 1.5M |

Health Technology

| -17.25% | O: 1.86% H: 4.79% C: 2.39%
briumvi presentation sclerosis treatment research therapeutics

---

MGM RESORTS & BETMGM STRENGTHEN RELATIONSHIP WITH KINDBRIDGE, FURTHERING SUPPORT FOR PROBLEM GAMBLING RESEARCH & TREATMENT
Published: 2024-03-01 (Crawled : 11:00) - prnewswire.com
MGM | $42.56 -0.68% 1.4M |

Consumer Services

| -0.99% | O: -0.76% H: 0.33% C: 0.02%
treatment research

---

BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
Published: 2024-02-28 (Crawled : 16:00) - globenewswire.com
BICX | $0.75 4.2K |

Health Care and Social Assistan...

| -21.88% | O: 2.08% H: 12.24% C: 2.04%
bicx104 million treatment pharmaceuticals research grant implant

---

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
Published: 2024-02-26 (Crawled : 15:30) - biospace.com/
LUNG | $7.59 1.2% 97K |

Health Technology

| -30.62% | O: -0.65% H: 3.35% C: -3.26%
aeriseal first treatment system trial

---

Binge-eating Disorder Treatment Market Research Report 2024
Published: 2024-02-23 (Crawled : 02:00) - prnewswire.com
VTRS | News A | $11.485 1.1% 2.4M |

Health Technology

| -14.97% | O: 0.0% H: 1.93% C: 1.27%
TNXP | $0.1572 0.26% 750K |

Health Technology

| -49.43% | O: 0.0% H: 4.3% C: 1.77%
report treatment research market

---

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
Published: 2024-02-20 (Crawled : 14:30) - prnewswire.com
FBLG | $11.52 3.78% 58K |

| -17.78% | O: 7.33% H: 0.0% C: -14.77%
sclerosis treatment research preclinical

---

Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹
Published: 2024-02-20 (Crawled : 14:00) - globenewswire.com
SCLX | $0.9036 -7.48% 740K |

| -47.59% | O: 0.53% H: 4.79% C: -3.72%
ztlido company anesthesiology publication treatment research results study

---

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
TGTX | $13.765 -3.4% 1.5M |

Health Technology

| 3.04% | O: -0.58% H: 0.76% C: -3.78%
briumvi sclerosis treatment research therapeutics

---

Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis
Published: 2024-02-14 (Crawled : 15:30) - biospace.com/
ATRA | $0.7136 -0.7% 440K |

Health Technology

| -6.51% | O: 6.48% H: 0.0% C: -6.07%
ata3219 drug lupus treatment application submission

---

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
Published: 2024-01-29 (Crawled : 15:30) - biospace.com/
CYTH | $1.21 13K |

Professional, Scientific, and T...

| -29.24% | O: 6.43% H: 1.58% C: -2.75%
patent disease alzheimer’s treatment application therapeutics

---

Biomunex Pharmaceuticals Announces the Start of a Phase 1 Clinical Trial for Its First-in-class Bispecific Antibody for the Treatment of Cancer
Published: 2024-01-24 (Crawled : 15:30) - biospace.com/
SNYNF | News | $94.25 480 |

Health Technology

| -8.58% | O: -3.01% H: 0.69% C: -0.75%
SNY | News | $46.765 -1.94% 950K |

Health Technology

| -6.03% | O: 0.92% H: 0.0% C: 0.0%
antibody start cancer treatment pharmaceuticals trial

---

Gainers vs Losers

58%

42%

Top 10 Gainers

CSSE 4 | $0.3831 151.54% 190M |

Consumer Services

CZOO | $11.04 121.24% 11M |

BOF | $1.87 59.83% 100M |

AMST | $3.18 59.0% 67M |

Technology Services

LICN | $0.85 51.79% 13M |

WIMI | $1.04 43.37% 17M |

Technology Services

SKIL 4 | $8.045 40.89% 230K |

Information

MULN | News | $3.805 39.38% 11M |

Information

RILY | $30.01 38.17% 11M |

Finance

MTC | $3.04 35.71% 6.7M |

Technology Services

---

Your saved searches

---